vs
AerSale Corp（ASLE）与Cytek Biosciences, Inc.（CTKB）财务数据对比。点击上方公司名可切换其他公司
AerSale Corp的季度营收约是Cytek Biosciences, Inc.的1.5倍（$90.9M vs $62.1M），AerSale Corp净利率更高（5.9% vs -70.9%，领先76.9%），Cytek Biosciences, Inc.同比增速更快（8.1% vs -4.0%），AerSale Corp自由现金流更多（$9.8M vs $-1.8M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 0.2%）
AerSale Corp总部位于美国佛罗里达州多拉市，是一家面向航空领域的全球供应商，主要为客运及货运航空公司、政府机构、跨国整机制造商与独立维修机构提供商用喷气飞机二手整机、发动机、航空耗材，并提供航空工程服务，同时该公司也是飞机机队回收协会的成员企业。
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
ASLE vs CTKB — 直观对比
营收规模更大
ASLE
是对方的1.5倍
$62.1M
营收增速更快
CTKB
高出12.1%
-4.0%
净利率更高
ASLE
高出76.9%
-70.9%
自由现金流更多
ASLE
多$11.5M
$-1.8M
两年增速更快
CTKB
近两年复合增速
0.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $90.9M | $62.1M |
| 净利润 | $5.4M | $-44.1M |
| 毛利率 | 34.1% | 52.9% |
| 营业利润率 | 7.8% | -9.0% |
| 净利率 | 5.9% | -70.9% |
| 营收同比 | -4.0% | 8.1% |
| 净利润同比 | 99.7% | -557.1% |
| 每股收益（稀释后） | $0.10 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASLECTKB
| Q4 25 | $90.9M | $62.1M | ||
| Q3 25 | $71.2M | $52.3M | ||
| Q2 25 | $107.4M | $45.6M | ||
| Q1 25 | $65.8M | $41.5M | ||
| Q4 24 | $94.7M | $57.5M | ||
| Q3 24 | $82.7M | $51.5M | ||
| Q2 24 | $77.1M | $46.6M | ||
| Q1 24 | $90.5M | $44.9M |
净利润ASLECTKB
| Q4 25 | $5.4M | $-44.1M | ||
| Q3 25 | $-120.0K | $-5.5M | ||
| Q2 25 | $8.6M | $-5.6M | ||
| Q1 25 | $-5.3M | $-11.4M | ||
| Q4 24 | $2.7M | $9.6M | ||
| Q3 24 | $509.0K | $941.0K | ||
| Q2 24 | $-3.6M | $-10.4M | ||
| Q1 24 | $6.3M | $-6.2M |
毛利率ASLECTKB
| Q4 25 | 34.1% | 52.9% | ||
| Q3 25 | 30.2% | 52.7% | ||
| Q2 25 | 32.9% | 52.3% | ||
| Q1 25 | 27.3% | 48.6% | ||
| Q4 24 | 31.4% | 58.5% | ||
| Q3 24 | 28.6% | 56.3% | ||
| Q2 24 | 28.2% | 54.6% | ||
| Q1 24 | 31.8% | 51.3% |
营业利润率ASLECTKB
| Q4 25 | 7.8% | -9.0% | ||
| Q3 25 | 4.0% | -17.6% | ||
| Q2 25 | 11.7% | -23.3% | ||
| Q1 25 | -10.1% | -36.1% | ||
| Q4 24 | 5.2% | 5.2% | ||
| Q3 24 | 2.4% | -8.2% | ||
| Q2 24 | -2.4% | -18.3% | ||
| Q1 24 | 5.2% | -23.9% |
净利率ASLECTKB
| Q4 25 | 5.9% | -70.9% | ||
| Q3 25 | -0.2% | -10.5% | ||
| Q2 25 | 8.0% | -12.2% | ||
| Q1 25 | -8.0% | -27.5% | ||
| Q4 24 | 2.9% | 16.8% | ||
| Q3 24 | 0.6% | 1.8% | ||
| Q2 24 | -4.7% | -22.4% | ||
| Q1 24 | 6.9% | -13.8% |
每股收益（稀释后）ASLECTKB
| Q4 25 | $0.10 | — | ||
| Q3 25 | $0.00 | — | ||
| Q2 25 | $0.18 | — | ||
| Q1 25 | $-0.10 | — | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.01 | — | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | $0.12 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.4M | $90.9M |
| 总债务越低越好 | $1.3M | — |
| 股东权益账面价值 | $424.4M | $341.7M |
| 总资产 | $640.5M | $461.5M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资ASLECTKB
| Q4 25 | $4.4M | $90.9M | ||
| Q3 25 | $5.3M | $93.3M | ||
| Q2 25 | $5.7M | $75.5M | ||
| Q1 25 | $4.7M | $95.3M | ||
| Q4 24 | $4.7M | $98.7M | ||
| Q3 24 | $9.8M | $162.3M | ||
| Q2 24 | $4.3M | $177.9M | ||
| Q1 24 | $2.6M | $168.8M |
总债务ASLECTKB
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $907.0K | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $376.0K | — | ||
| Q2 24 | $522.0K | — | ||
| Q1 24 | $3.5M | — |
股东权益ASLECTKB
| Q4 25 | $424.4M | $341.7M | ||
| Q3 25 | $417.1M | $378.6M | ||
| Q2 25 | $415.9M | $377.6M | ||
| Q1 25 | $406.5M | $379.6M | ||
| Q4 24 | $455.6M | $395.7M | ||
| Q3 24 | $451.5M | $385.5M | ||
| Q2 24 | $449.8M | $389.1M | ||
| Q1 24 | $452.0M | $392.6M |
总资产ASLECTKB
| Q4 25 | $640.5M | $461.5M | ||
| Q3 25 | $646.3M | $494.9M | ||
| Q2 25 | $646.7M | $493.3M | ||
| Q1 25 | $646.1M | $482.6M | ||
| Q4 24 | $604.7M | $499.5M | ||
| Q3 24 | $601.5M | $491.2M | ||
| Q2 24 | $598.7M | $483.7M | ||
| Q1 24 | $571.7M | $492.1M |
负债/权益比ASLECTKB
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.01× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.4M | $-771.0K |
| 自由现金流经营现金流 - 资本支出 | $9.8M | $-1.8M |
| 自由现金流率自由现金流/营收 | 10.8% | -2.9% |
| 资本支出强度资本支出/营收 | 1.7% | 1.6% |
| 现金转化率经营现金流/净利润 | 2.11× | — |
| 过去12个月自由现金流最近4个季度 | $-29.1M | $-8.8M |
8季度趋势，按日历期对齐
经营现金流ASLECTKB
| Q4 25 | $11.4M | $-771.0K | ||
| Q3 25 | $-8.9M | $-3.9M | ||
| Q2 25 | $19.8M | $108.0K | ||
| Q1 25 | $-45.2M | $-125.0K | ||
| Q4 24 | $37.5M | $2.0M | ||
| Q3 24 | $10.4M | $13.2M | ||
| Q2 24 | $-15.3M | $6.2M | ||
| Q1 24 | $-21.5M | $4.0M |
自由现金流ASLECTKB
| Q4 25 | $9.8M | $-1.8M | ||
| Q3 25 | $-9.8M | $-4.6M | ||
| Q2 25 | $18.6M | $-1.5M | ||
| Q1 25 | $-47.6M | $-974.0K | ||
| Q4 24 | $32.3M | $1.1M | ||
| Q3 24 | $8.9M | $12.2M | ||
| Q2 24 | $-18.9M | $5.2M | ||
| Q1 24 | $-25.0M | $3.4M |
自由现金流率ASLECTKB
| Q4 25 | 10.8% | -2.9% | ||
| Q3 25 | -13.8% | -8.7% | ||
| Q2 25 | 17.3% | -3.2% | ||
| Q1 25 | -72.4% | -2.3% | ||
| Q4 24 | 34.0% | 1.9% | ||
| Q3 24 | 10.7% | 23.7% | ||
| Q2 24 | -24.6% | 11.0% | ||
| Q1 24 | -27.7% | 7.6% |
资本支出强度ASLECTKB
| Q4 25 | 1.7% | 1.6% | ||
| Q3 25 | 1.3% | 1.3% | ||
| Q2 25 | 1.1% | 3.5% | ||
| Q1 25 | 3.7% | 2.0% | ||
| Q4 24 | 5.6% | 1.6% | ||
| Q3 24 | 1.9% | 2.0% | ||
| Q2 24 | 4.7% | 2.3% | ||
| Q1 24 | 3.9% | 1.3% |
现金转化率ASLECTKB
| Q4 25 | 2.11× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.31× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 13.89× | 0.21× | ||
| Q3 24 | 20.52× | 14.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | -3.42× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASLE
| Products | $57.8M | 64% |
| Maintenance | $23.2M | 26% |
| Leasing Arrangements | $9.9M | 11% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
